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Michal Abrahamowicz1,2, Karen Leffondré1,7 and Jack Siemiatycki1,8*Abstract
Background: There is conflicting evidence regarding the associations between cigarette smoking and glioma or
meningioma. Our purpose is to provide further evidence on these possible associations.
Methods: We conducted a set of case–control studies in three Canadian cities, Montreal, Ottawa and Vancouver.
The study included 166 subjects with glioma, 93 subjects with meningioma, and 648 population-based controls. A
lifetime history of cigarette smoking was collected and various smoking indices were computed. Multivariable
logistic regression was used to estimate odds ratios (ORs) between smoking and each of the two types of brain
tumours.
Results: Adjusted ORs between smoking and each type of brain tumour were not significantly elevated for all
smokers combined or for smokers with over 15 pack-years ((packs / day) x years) accumulated. We tested for
interactions between smoking and several sociodemographic variables; the interaction between smoking and
education on glioma risk was significant, with smoking showing an elevated OR among subjects with lower
education and an OR below unity among subjects with higher education.
Conclusion: Except for an unexplained and possibly artefactual excess risk in one population subgroup, we found
little or no evidence of an association between smoking and either glioma or meningioma.
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The incidence of primary intracranial tumours in Western
Europe, North America, and Australia ranges from 4 to 11
per 100,000 population per year. This is approximately
four times the incidence reported in the lowest risk re-
gions of the world, although some of this variability may
be due to differences in access to diagnostic services [1,2].
In the United States the age-adjusted incidence increased
by about 19% in men and 27% in women between 1973
and 2003 [1].
Glioma and meningioma are the two most common
types of brain tumours, comprising approximately 75%
of all brain tumours [1-3]. Gliomas are more common in* Correspondence: j.siemiatycki@umontreal.ca
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unless otherwise stated.men; in the US, they are more common among whites
than among blacks and Hispanics [1]. The median age at
diagnosis is 53 years [1]. Due to the relatively young age
at presentation and poor prognosis, gliomas account for
a substantial number of years of life lost. While some
forms of glioma are associated with specific genetic mu-
tations or inherited syndromes [2,3], such as neuro-
fibromatosis type 1 and 2 [2], the only modifiable risk
factor unequivocally associated with glioma is high dose
therapeutic ionizing radiation [2,3]. Meningioma, less
common than glioma, is more common in women than
men and has a later median age at diagnosis of 64 years
[1]. Like glioma, meningioma is associated with ionizing
radiation and with neurofibromatosis type 2 (NF2) [4]. A
history of tuberous sclerosis has also been reported to
increase the risk of brain tumour [1]. For the most part,
the etiology of brain tumours is not understood; in par-
ticular it is not known if exogenous chemicals are cap-
able of causing human brain tumours.. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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ally absorbed chemical carcinogens including, among
others, polycyclic aromatic hydrocarbons (PAHs) and N-
nitroso compounds. Among smokers, tobacco smoke is by
far the greatest source of exposure to N-nitroso compounds
[5]. These potent agents are associated with tumours of the
nervous system in animals, whether administered transpla-
centally [6] or intravenously [7,8]. Although nicotine may
increase the permeability of the blood brain barrier [9], it is
unknown if N-nitroso compounds penetrate to human
brain tissue [10].
From a public health perspective, cigarette smoking is
the single most important cause of human cancer. In
high-income countries, tobacco smoking is responsible for
25 – 30% of overall cancer mortality [11]. Smoking is asso-
ciated with elevated rates of cancer of the lung, bladder,
cervix, colon and rectum, oesophagus, kidney, larynx,
mouth and throat, pancreas, stomach, nasal cavity, liver,
ovaries, and with acute myelogenous leukemia [12]. Be-
cause tobacco smoking causes tumours at multiple sites, it
is conceivable that smoking could affect brain tumour risk.
If smoking were shown to be a risk factor, it would consti-
tute an important “proof of principle” that exogenous che-
micals are capable of causing human brain tumours.
Most case–control studies have not shown increased
risk of glioma in relation to tobacco smoking [5,13-20];
others found elevated relative risks that were not statisti-
cally significant or confined to subgroups of the popula-
tion studied [21-24]. Among cohort studies, some found
no association [25-27] and some found significant posi-
tive associations in women but not men [28] and in a
study of women only [29]. A recent meta-analysis on
smoking and glioma found no overall association when
case–control and cohort studies were pooled, although
there was a small but significant increased risk among
cohort studies [30]. For meningioma, some case–control
studies found no evidence of increased risk [16,27,31,32]
and others found an association in one sex but not the
other [17,18,33-35]. Two cohort studies did not find ele-
vated risk [25,27]. A review concluded that the evidence
regarding smoking in relation to glioma and meningi-
oma is largely null, but still inconclusive [1]. A more re-
cent large prospective study found no association
between smoking and carcinomas of the brain [36]. Fi-
nally, a recent comprehensive evaluation of the cancer
risks associated with smoking conducted by the Inter-
national Agency for Research on Cancer did not list the
nervous system as a target organ for tobacco-related
cancer in humans [37].
Because of the rarity of brain tumours and the difficulty
of mounting large studies, it is important to increase the
number of good quality studies in the expectation that
true patterns will emerge from the juxtaposition of a large
number of published results. The present analysis of thesmoking data from a Canadian case–control study of
brain tumours is intended to contribute to the growing
body of scientific evidence on which a more complete
evaluation of the association between smoking and brain
tumour risk can be based.
Methods
Design
The INTERPHONE study is an international consortium
of case–control studies of glioma, meningioma, acoustic
neurinoma and parotid gland tumours, with the primary
purpose of assessing mobile phone use as a possible risk
factor. Its methodology has been described in detail else-
where [38]. Sixteen centres in 13 countries used a com-
mon core protocol. Three Canadian centres participated,
one each in Montreal, Ottawa and Vancouver. The
present report derives from the Canadian component of
the INTERPHONE study.
Subjects
Because of the emphasis on the use of mobile telephones as
a possible risk factor for brain cancer, the study focused on
relatively young people. Eligible cases were males and fe-
males aged 30 to 59 years residing in the study regions and
diagnosed during the study period with a confirmed first
primary glioma or meningioma. Montreal subjects were
also required to be Canadian citizens. Recruitment took
place between 2002 and 2004. All diagnoses were histologi-
cally confirmed or based on unequivocal diagnostic im-
aging. Each centre established procedures for the rapid
ascertainment of cases from their respective study bases.
Close relationships with hospital-based tumour registries,
diagnostic and treatment units and medical records depart-
ments were maintained so that cases were not missed and
necessary authorizations to contact cases were obtained.
Since cases in Vancouver were ascertained via a provincial
cancer registry and cases in Montreal and Ottawa by
reviewing files of all major diagnostic facilities, it is reason-
able to assume that we ascertained upwards of 90% of all
eligible cases of glioma.
Sampling of controls varied among centres. Sources of
controls were: electoral lists in Montreal, random-digit
dialling in Ottawa, and the British Columbia provincial
health insurance agency in Vancouver. In each centre,
controls were selected to approximate the age and sex
distribution of the cases series, in Ottawa and Vancouver
by using individual matching and in Montreal by strati-
fied sampling.
The study was approved by the research ethics boards
of all the centres involved. All cases for whom physician
authorization had been obtained and all controls were
informed about the study and asked to participate. Writ-
ten informed consent was obtained from all participating
subjects.
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Information on exposure and covariates was gathered by
a trained interviewer using a computerized questionnaire
during interviews, mainly face-to-face, with the study
subject or a proxy. The questionnaire included items on
socio-demographic factors, mobile phone use, cigarette
smoking, occupational exposure to electromagnetic
fields, and medical history, including medical exposure
to ionizing radiation. Demographic data included birth
date, sex, address and highest attained education, coded
in five categories. Using subjects’ addresses and postal
codes, we were able to derive the median household in-
come of the subject’s area of residence, as obtained from
Canadian census data. Smoking data collected included
history of ever regular smoking (defined as daily smok-
ing for six months or more), including age at which
regular smoking started, age at cessation, periods of ab-
stinence, and average amount smoked during each
smoking period. Cases and controls were assigned a ref-
erence date, namely, the date of diagnosis for cases and
the date of interview for controls. Because smoking
habits often change during periods of illness even prior
to diagnosis and because of the long latency between ex-
posure to tobacco smoke and tumour diagnosis, tobacco
consumption within two years of the reference date was
discounted. Questionnaires included items on possible
risk factors for brain tumour such as neurofibromatosis,
tuberosclerosis, and prior therapeutic radiation. Family
history of primary brain tumour in first-degree relatives
was also examined.
Data analysis
Notwithstanding the fact that controls were selected
separately for each type of brain tumour, and that there
were individual matching algorithms in two of the cen-
tres, for the present analysis, each case series was com-
pared with the entire pool of eligible interviewed
controls. This was done for several reasons. First, the
low response rates among controls in particular would
have led to elimination of many subjects and significant
loss of information had we insisted on maintaining the
individual matching when analysing the results. Second
the matching criteria, age and sex, do not provide close
covariate control, like neighbours or friends might.
Third, the main limitation of this study is statistical
power, and the inclusion of the largest possible set of
controls maximizes the power. This strategy led to the
two sets of results (glioma and meningioma) not being
independent of each other because of the common con-
trol series. However, it was felt that the efficiency and
statistical power gain from this double use of the con-
trols was more important than the maintenance of stat-
istical independence between the two sets of results.
Unconditional multivariable logistic regression was usedto examine the relationship between case–control status
and smoking. Three smoking metrics were modelled,
each in a separate model: ever/never regular smoking,
duration of smoking in years (nonsmokers ; 1–20 years;
>20 years) and pack-years of cigarettes smoked (non-
smokers; 1 – 15 pack-years (packs per day x years); >15
pack-years). These cutpoints were selected in order to
give approximately equal sample sizes in each group.
The following covariates were included: age (30–39,
40–49 and 50–59 years), sex, education (lower defined
as completion of high school or less and higher defined
as any post-secondary education), and study region
(Montreal, Ottawa or Vancouver). While we derived the
median census tract income of the neighbourhood of
residence, this variable was not included in the models
because it was highly correlated with education and the
small number of subjects contra-indicated the loss of
additional degrees of freedom. Also, we did not include
variables for cellphone usage because that has not been
recognized as definitely carcinogenic, and to the extent
that there is any evidence of risk, it is only in a small
fraction of users and the corresponding relative risk esti-
mates are very low. In addition to the overall study sam-
ple analyses, we conducted various subgroup analyses by
sex and other characteristics.
Following the observation of some differences in findings
between men and women, we decided to explore possible
effect modification between smoking (ever/never) and each
of the following covariates: sex, age decade as described
above, education level as described above, and study centre.
We examined these interactions using logistic regression
with backward elimination, removing the least statistically
significant interaction in each step. We did not adjust the
alpha level for multiple comparisons.
Results
There were 271 eligible gliomas, 133 eligible meningi-
omas and 1,325 eligible controls. Successful interviews
were obtained for 166 (61.3%) gliomas, 93 (69.9%) men-
ingiomas and 648 (48.9%) controls. Response rates were
rather similar for males and females. Table 1 summarizes
the reasons for non-participation.
Given the somewhat low participation rates, there was
some concern about possible biases due to unrepresen-
tative participants. In order to detect possible self-
selection bias in respondents, we instituted a policy of
asking controls who refused to participate in the lengthy
interview if they would agree to answer a 5-minute
questionnaire that included a question on attained edu-
cation level. Among the 108 nonparticipant controls
who agreed to provide such information, the percentage
who had greater than high school education was 50.9%,
whereas among the 648 participant controls in the main
study, the percentage was 71.3%. To the extent that the
Table 1 Response rates and reasons for non-response among brain cancer cases and controls in Canada
Response Glioma cases Meningioma cases Controls
N % N % N %
Eligible 271 100.0 133 100.0 1325 100.0
Responded 166 61.3 93 69.9 648 48.9
Non-response
Subject refused 20 7.4 17 12.8 428 32.3
Physician refused 19 7.0 10 7.5 - -
Subject deceased or ill, no proxy available 48 17.7 3 2.3 6 0.5
Untraced or other 18 6.6 10 7.5 243 18.3
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tionnaire were representative of all nonparticipants, this
indicates that participants in the main study had higher
education than nonparticipants, at least among controls.
As smoking is often inversely related to education level,
this raises the possibility of confounding by educational
attainment and highlights the importance of controlling
for education level in analyses of smoking as a risk fac-
tor. Unfortunately we had no information on smoking
habits of non-participants.
Table 2 presents selected demographic data for participat-
ing cases and controls. As expected, males predominated
among glioma cases and females among meningioma cases.
Cases had slightly lower education level and slightly lower
median census tract income than controls. Glioma cases
tended to be younger than controls and meningioma cases
tended to be older than controls, as expected. While there
were some proxy respondents among cases, there were
hardly any for controls. Proxies were usually the surviving
spouse or offspring. In order to assess whether this may
have biased the findings, we reanalysed the study data, ex-
cluding proxy responses altogether. These results were very











Education > high school, %
Census tract median household income, C$, mean (standard deviationThere were very few subjects with neurofibromatosis,
tuberous sclerosis, history of therapeutic radiation, or
family history of primary brain tumour in first-degree
relatives. These variables were therefore not included in
smoking analyses.
Table 3 presents lifetime smoking patterns among cases
and among controls, by sex. The lifetime prevalence of
smoking and the cumulative pack-years of smoking were
somewhat higher among males than females. Crude differ-
ences in smoking parameters between cases and controls
were rather small; among males the smoking rates were
slightly higher among glioma and meningioma cases than
among controls, whereas smoking rates in females were
slightly lower among glioma cases than among controls.
Smoking was associated with sex, with age and with educa-
tion. For male controls, 64% of subjects in the lower educa-
tion stratum were ever regular smokers and the smokers
had a mean of 28.5 pack-years whereas 53% of subjects in
the higher education stratum were ever regular smokers
and those smokers had a mean of 18.9 pack-years. For fe-
male controls, 56% of subjects in the lower education
stratum were ever regular smokers and the smokers had a















(sd)) 46,557 (16,287) 44,261 (16,687) 47,302 (17,350)
Table 3 Comparison of smoking exposure measures between cases and controls, stratified by sex
Smoking exposure Glioma cases Meningioma cases Controls
Males N = 105 N = 26 N = 317
Ever regular smokers, % 61.0 65.4 55.8
Current smokers, % 26.7 46.2 24.6
Ex-smokers, % 34.3 19.2 31.2
Smokers only N = 64 N = 17 N = 177
Cig/day, mean (sd) 20.4 (13.8) 20.5 (12.4) 19.7 (12.8)
Duration, mean years (sd) 18.9 (11.1) 21.7 (11.5) 20.6 (11.4)
Pack-years, mean (sd) 21.9 (21.4) 21.9 (17.0) 21.9 (19.8)
Females N = 61 N = 67 N = 331
Ever regular smokers, % 39.3 50.7 48.3
Current smokers, % 19.7 20.9 19.9
Ex-smokers, % 19.7 29.9 28.4
Smokers only N = 24 N = 34 N = 160
Cig/day, mean (sd) 17.2 (10.1) 18.8 (13.2) 15.6 (11.7)
Duration, mean years (sd) 18.9 (10.3) 20.1 (10.8) 18.7 (11.2)
Pack-years, mean (sd) 18.5 (18.3) 20.9 (18.5) 16.2 (16.6)
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those smokers had a mean of 14.0 pack-years.
Table 4 presents adjusted odds ratios (ORs) and 95%
confidence intervals (CIs) between various smoking
metrics and brain tumours. Because smoking behaviour,
glioma incidence and meningioma incidence differ be-
tween males and females, results are presented for males
and females both separately and together. The overall
OR between ever regular smoking and glioma was 0.96
(95% CI: 0.67 – 1.38) and that between smoking and
meningioma was 1.09 (95% CI: 0.69 – 1.72). ORs were
higher among males than females. Nevertheless, no ORs
differed from unity to a statistically significant degree,
and there were no consistent dose–response relation-
ships with pack-years or smoking duration.
Because the use of proxy response for subjects who
were too ill or deceased could have introduced error or
bias in the data, we carried out analyses analogous to
those in Table 4, but restricted to self-respondents only.
There were no important differences in ORs between
the two sets of results (results not shown).
We next examined second-order models with potential
interaction terms or effect modifiers of the relationship
between ever regular smoking and glioma and meningi-
oma. For glioma, there was no statistically significant
evidence of effect modification by sex, age, or other po-
tential effect modifier, except that among males there
was a significant interaction between ever regular smok-
ing and education level (p = 0.032). Among females, the
interaction was suggestive but did not reach statistical
significance (p = 0.066). These results are shown in
Table 5. The OR between ever regular smoking andglioma among males and females combined was 1.33
(95% CI: 0.62 – 2.85) in the low education stratum and
0.48 (95% CI: 0.25 – 0.91) in the high education stratum.
The apparent interaction between smoking and educa-
tion level was especially striking among males. In order
to evaluate the possibility that smokers with lower edu-
cation may have been heavier smokers, we added pack
years to the model. It was not statistically significant and
did not meaningfully change the ORs of the ever regular
smoking variable or the ever regular smoking-education
interaction. Finally, while interaction terms for ever
smoking and sex were not statistically significant at the
alpha = 0.05 level, Table 5 shows noteworthy differences
in ever regular smoking OR by sex.
For meningioma, there was no statistically significant
evidence of effect modification of ever regular smoking
by age, sex, education or study centre (results not
shown), and none that resulted in a statistically signifi-
cant elevation in OR for ever smoking.Discussion
Cigarette smoke, a complex mixture of chemical sub-
stances, is the single most important cause of human
cancer. It has already been shown to induce tumours in
numerous organs and tissues. While the carcinogenicity
of smoking is not in doubt and the recommendation to
reduce or eliminate smoking in society would hardly be
affected by the identification of new tumour sites af-
fected by smoking, the investigation of a possible link
between smoking and brain tumours is important for
our understanding of brain tumour aetiology.
Table 4 Odds ratios between smoking and brain tumour by sex, ever regular smoking, smoking duration and
pack-years
Sex/smoking stratum Glioma Meningioma
Ca/Co OR (95% CI) Ca/Co OR (95% CI)
Males and females combined
Never regular smokers 78/311 1 42/311 1
Ever regular smokers 88/337 0.96 (0.67-1.38) 51/337 1.09 (0.69-1.72)
>0 to <20 years 51/177 1.05 (0.70-15.96) 25/177 1.10 (0.64-1.89)
≥ 20 years 37/160 0.84 (0.53-1.34) 26/160 1.08 (0.62-1.88)
>0 to <15 pack-years 43/173 0.97 (0.63-1.49) 22/173 0.93 (0.53-1.62)
≥15 pack-years 45/164 0.95 (0.61-1.48) 29/164 1.28 (0.75-2.20)
Males only
Never regular smokers 41/140 1 9/140 1
Ever regular smokers 64/177 1.28 (0.82-2.02) 17/177 1.34 (0.57-3.17)
>0 to <20 years 37/88 1.36 (0.80-2.30) 16/89 1.47 (0.56-3.90)
≥ 20 years 27/89 1.02 (0.57-1.82) 18/71 1.21 (0.44-3.36)
>0 to <15 pack-years 30/75 1.32 (0.75-2.30) 17/98 1.00 (0.32-3.11)
≥15 pack-years 34/102 1.10 (0.63-1.89) 17/62 1.61 (0.63-4.13)
Females only
Never regular smokers 37/171 1 33/171 1
Ever regular smokers 24/160 0.73 (0.41-1.28) 34/160 0.98 (0.57-1.68)
>0 to <20 years 14/89 0.78 (0.40-1.53) 9/88 0.99 (0.51-1.92)
≥ 20 years 10/71 0.66 (0.31-1.42) 8/89 0.98 (0.50-1.89)
>0 to <15 pack-years 13/98 0.68 (0.34-1.36) 5/75 0.93 (0.48-1.78)
≥15 pack-years 11/62 0.78 (0.37-1.65) 12/102 1.05 (0.53-2.08)
Three models were estimated: one model with ever regular smoking as a binary variable and one each with three categorical levels of duration and pack-years of
smoking. The reference groups in all comparisons are never regular smokers. Analyses were adjusted for age (decades); sex (in the analysis of males and females
combined); education level (low, high); and region (Montreal, Ottawa, Vancouver). Covariates were removed from the model if they were non-significant and did
not change any of the smoking ORs by more than 10%.
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tobacco smoke, such as PAHs and N-nitroso com-
pounds, might reach brain tissue, animal experimenta-
tion suggests that N-nitroso compounds are potent
animal nervous system carcinogens. However, previous
epidemiologic research has not provided a clear indica-
tion of whether smoking can increase the risk of brain
tumours. While most studies have failed to demonstrate
any excess risks [5,13-20,25-27,30-32], some studies have
found excess risks in their entire population or in some
subpopulation [28,29,34,35].
The present study did not demonstrate an overall associ-
ation between ever regular smoking and either glioma or
meningioma, nor was there convincing evidence of an
exposure-response relationship between smoking and ei-
ther of these lesions. The only exception to a consistent
pattern of null results for smoking and brain tumours was
the unexpected finding of a higher OR between ever regular
smoking and glioma among subjects with lower education
compared to that among subjects with higher education.
This resulted in a statistically significant elevation in theOR for ever regular smokers among males with lower edu-
cation. However, this was accompanied by a statistically sig-
nificant deficit of risk among females with higher
education. In other words, the excess risk due to smoking
among the lower educated was concentrated among males,
while the deficit of risk due to smoking among the higher
educated was concentrated among females. The participa-
tion proportions were lower among controls than among
cases. While low participation proportions do not necessar-
ily imply bias, it is possible that participating controls may
have been unrepresentative of all eligible control subjects,
at least for education level. Our comparison of subjects eli-
gible to be controls found that participants tended to have
higher educational attainment than non-participants. Our
comparison of smoking measures among controls with
lower and higher educational attainment found that those
with lower attainment were more likely to have ever
smoked and the smokers among them smoked more heav-
ily. It is therefore possible that subjects with lower educa-
tion and greater smoking were under-represented in our
control group. We examined the possible effect of smoking
Table 5 Odds ratios between ever versus never regular smoking for glioma by education level
Sex/education stratum Glioma
Ca/Co OR (95% CI)
Males and females combined
Ever regular smoking-education interaction p = 0.010
Ever versus never regular smoking, lower education 64/186 1.33 (0.62-2.85)
Ever versus never regular smoking, higher education 102/462 0.48 (0.25-0.91)
Males only
Ever regular smoking-education interaction p = 0.032
Ever versus never regular smoking, lower education 39/87 2.79 (1.08-7.18)
Ever versus never regular smoking, higher education 66/230 0.85 (0.49-1.48)
Females only
Ever regular smoking-education interaction p = 0.066
Ever versus never regular smoking, lower education 25/99 1.31 (0.53-3.22)
Ever versus never regular smoking, higher education 36/232 0.42 (0.19-0.95)
Models were of ever regular smoking as a binary variable, with the addition of an interaction term of ever regular smoking and education level. The reference
groups in all comparisons are never regular smokers in the appropriate sex and education stratum. Analyses were adjusted for age (decades); sex (in the analysis
of males and females combined); and region (Montreal, Ottawa, Vancouver). Covariates were removed from the model if they were non-significant and did not
change any of the smoking ORs by more than 10%.
Vida et al. Environmental Health 2014, 13:55 Page 7 of 9
http://www.ehjournal.net/content/13/1/55intensity on the risk associated with ever regular smoking
by adding pack years to the ever regular smoking model for
both sexes together and for males and females separately.
In none of these models was pack years statistically signifi-
cant, nor did it meaningfully alter the ORs for ever regular
smoking or for the interaction between ever smoking and
education. Regarding the sex distribution of our samples,
while the proportion of males among controls was lower
than that among glioma cases and higher than that among
meningioma cases, similar interaction effects were seen in
males and females together and separately. Whether the
pattern of interactions we report was due to a real effect
modification of smoking by education and sex or to some
combination of chance and bias is difficult to answer from
our dataset. There are some features that argue against a
causal interpretation, including the following: there was no
prior hypothesis for such interactions; they arose in a mul-
tiple testing set of subgroup analyses; they would imply an
implausible protective effect of smoking in one part of the
population [39]; there was no clear dose–response relation-
ship demonstrated; and low participation rates raise the
possibility of selection biases which might have unusual
subgroup patterns. Before engaging in speculation on pos-
sible biological pathways to explain possible effect modifica-
tions by sex or education, both of which are proxies for
complex sets of environmental, social and biological vari-
ables, it would be useful if other investigators would exam-
ine whether such interactions can be detected in other
datasets.
Our study had several strengths. It was based on well-
substantiated cases from three Canadian regions, a large
population control series, and detailed lifetime smoking
histories obtained via face-to-face interviews by trainedinterviewers. It is generally considered that smoking is
reported with reasonable accuracy, and, since smoking is
not generally considered to be a cause of brain tumours,
it is unlikely that cases and controls would have differen-
tially reported their smoking histories. It is unlikely that
the use of proxy respondents for some subjects induced
bias, since parallel analyses restricted to self-report sub-
jects yielded ORs similar to those shown.
The main limitations included the limited numbers of
cases and the relatively low response rates in some sub-
groups. Difficulty in recruitment is becoming a problem
of increasing importance in epidemiologic studies, in-
cluding the INTERPHONE study [38,40,41], and our
participation proportions are consistent with this trend.
Theoretically, depending on the true but unknown
smoking patterns among nonparticipants, it would be
possible that nonrepresentative control series could have
masked a true overall effect or created spurious effects
in some subgroups. Unfortunately, without data on
smoking patterns among nonparticipants, we cannot
infer whether this did or did not bias our estimated ORs.
However, one indirect index of overall representativeness
comes from the comparison of smoking rates in our
control group with published national data on smoking
rates in Canada [42]. The fraction of current smokers re-
ported by our participant control group was 22.2% over-
all, 24.6% among males and 19.9% among females. This
is similar to 2003 national Canadian averages for the
35–64 year age range of 25.2% overall, 27.2% among
males and 23.2% among females [43]. Because of differ-
ent study areas between the national survey and our in-
vestigation, different sampling schemes and different
instruments, we cannot expect identical estimates, but
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judging the representativeness of our participants.
A final caveat pertains to the fact that our study subjects
were 30 to 59 years of age. It is conceivable that there
might be a long latency period for tobacco-induced brain
tumours, and that consequently any risk due to smoking
would only be detectable in older brain tumour cases. Our
data are therefore only informative regarding possible
risks that manifest before the age of 60.Conclusion
Our study did not demonstrate a significant overall excess
risk of glioma or meningioma with smoking. Given the lim-
ited numbers of cases, however, we cannot affirm with con-
fidence that our results demonstrate an absence of a true
effect. Subgroup analyses indicated excess risks of glioma
due to smoking among males with lower educational at-
tainment, accompanied by a decreased risk due to smoking
among females with high educational attainment. This sta-
tistically significant interaction between ever smoking, sex
and education may merit further exploration.Financial support
The Montreal data collection was funded by a grant
from the Canadian Institutes of Health Research (project
MOP-42525) and the analysis was funded by the Guzzo-
SRC Chair in Environment and Cancer. Dr. Siemiatycki
had salary support from the Canada Research Chair pro-
gramme. Dr. Parent had salary support from the Fonds
de recherche en santé du Québec. Dr. Abrahamowicz
is supported by the James McGill Chair at McGill
University. The Ottawa and Vancouver centres were sup-
ported by a university-industry partnership grant from
the Canadian Institutes of Health Research (CIHR), the
latter including partial support from the Canadian
Wireless Telecommunications Association. The CIHR
university-industry partnerships program also includes
provisions that ensure complete scientific independence
of the investigators. Dr. Krewski is the Natural Sciences
and Engineering Research Council of Canada Chair in
Risk Science at the University of Ottawa. Coordina-
tion of the INTERPHONE study and development of
the study instruments were supported by funding from
the European Fifth Framework Program, “Quality of Life
and Management of Living Resources” [contract QLK4-
CT-1999901563] and the International Union against
Cancer (UICC). The UICC received funds for this pur-
pose from the Mobile Manufacturers’ Forum and GSM
Association. Provision of funds to the INTERPHONE
study investigators via the UICC was governed by ag-
reements that guaranteed INTERPHONE's complete
scientific independence. The terms of these agreements
are publicly available at http://www.interphone.iarc.fr.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
SV performed the data analysis and wrote the manuscript. EC was principle
investigator of the international INTERPHONE study and contributed to the
analysis of the present study. LR, JS, DK, MM, KL, and M-EP contributed to
the local implementation of the international INTERPHONE study design. LR
was coordinator for the international INTERPHONE study, was responsible for
quality control of data collection, contributed to questionnaire development,
and provided assistance with data management and analysis. JS, DK and MM
were principal investigators of the international INTERPHONE study at the
Montreal, Ottawa and Vancouver sites, respectively. KL provided assistance
with the parameterization of smoking variables and with modeling strategy.
M-EP was participating author of the INTERPHONE study at the Montreal site
and provided assistance with data analysis. MA provided statistical advice
and assistance with data analysis. All authors reviewed and edited the
manuscript.
Acknowledgements
We thank Louise Nadon, Marie-Claire Goulet and Jerome Asselin for their in-
volvement in data collection and data management.
Author details
1Centre de Recherche, Centre hospitalier de l’Université de Montréal (CHUM),
Montréal, Québec, Canada. 2McGill University, Montréal, Québec, Canada.
3Centre for Research in Environmental Epidemiology (CREAL), Municipal
Institute of Medical Research (IMIM), CIBERESP, Barcelona, Spain. 4McLaughlin
Centre for Population Health Risk Assessment, University of Ottawa, Ottawa,
Canada. 5British Columbia Cancer Agency, Vancouver, Canada. 6INRS-Institut
Armand-Frappier, Université du Québec, Laval, Québec, Canada. 7University
of Bordeaux, ISPED, Centre INSERM U897-Epidemiology-Biostatistics,
Bordeaux, France. 8Guzzo-SRC Research Chair in Environment and Cancer,
Centre de Recherche, Centre hospitalier de l’Université de Montréal (CHUM),
850, rue St-Denis, room S02-458, Montreal, Quebec H2X 0A9, Canada.
Received: 12 May 2014 Accepted: 23 June 2014
Published: 27 June 2014
References
1. Fisher JL, Schwartzbaum JA, Wrensch M, Wiemels JL: Epidemiology of brain
tumors. Neurol Clin 2007, 25(4):867–890. vii.
2. Ohgaki H, Kleihues P: Epidemiology and etiology of gliomas.
Acta Neuropathol 2005, 109(1):93–108.
3. Wrensch M, Fisher JL, Schwartzbaum JA, Bondy M, Berger M, Aldape KD:
The molecular epidemiology of gliomas in adults. Neurosurg Focus 2005,
19(5):E5.
4. Marosi C, Hassler M, Roessler K, Reni M, Sant M, Mazza E, Vecht C:
Meningioma. Crit Rev Oncol Hematol 2008, 67(2):153–171.
5. Zheng T, Cantor KP, Zhang Y, Chiu BC, Lynch CF: Risk of brain glioma not
associated with cigarette smoking or use of other tobacco products in
Iowa. Cancer Epidemiol Biomarkers Prev 2001, 10(4):413–414.
6. Preston-Martin S, Yu MC, Benton B, Henderson BE: N-Nitroso compounds
and childhood brain tumors: a case–control study. Cancer Res 1982,
42(12):5240–5245.
7. Maekawa A, Mitsumori K: Spontaneous occurrence and chemical
induction of neurogenic tumors in rats–influence of host factors and
specificity of chemical structure. Crit Rev Toxicol 1990, 20(4):287–310.
8. Bogovski P, Bogovski S: Animal Species in which N-nitroso compounds
induce cancer. Int J Cancer 1981, 27(4):471–474.
9. Hawkins BT, Egleton RD, Davis TP: Modulation of cerebral microvascular
permeability by endothelial nicotinic acetylcholine receptors. Am J
Physiol Heart Circ Physiol 2005, 289(1):H212–H219.
10. Connelly JM, Malkin MG: Environmental risk factors for brain tumors.
Curr Neurol Neurosci Rep 2007, 7(3):208–214.
11. Irigaray P, Newby JA, Clapp R, Hardell L, Howard V, Montagnier L, Epstein S,
Belpomme D: Lifestyle-related factors and environmental agents causing
cancer: an overview. Biomed Pharmacother 2007, 61(10):640–658.
12. Smoking and cancer. [http://www.cancer.ca/en/prevention-and-screening/
live-well/smoking-and-tobacco/smoking-and-cancer/?region=qc]
Vida et al. Environmental Health 2014, 13:55 Page 9 of 9
http://www.ehjournal.net/content/13/1/5513. Preston-Martin S, Mack W, Henderson BE: Risk factors for gliomas and
meningiomas in males in Los Angeles county. Cancer Res 1989,
49(21):6137–6143.
14. Brownson RC, Reif JS, Chang JC, Davis JR: An analysis of occupational risks
for brain cancer. Am J Public Health 1990, 80(2):169–172.
15. Hochberg F, Toniolo P, Cole P, Salcman M: Nonoccupational risk indicators
of glioblastoma in adults. J Neurooncol 1990, 8(1):55–60.
16. Schlehofer B, Kunze S, Sachsenheimer W, Blettner M, Niehoff D, Wahrendorf
J: Occupational risk factors for brain tumors: results from a population-
based case–control study in Germany. Cancer Causes Control 1990,
1(3):209–215.
17. Preston-Martin S, Mack W: Gliomas and meningiomas in men in Los
Angeles county: investigation of exposures to N-nitroso compounds.
IARC Sci Publ 1991, 105:197–203.
18. Ryan P, Lee MW, North B, McMichael AJ: Risk factors for tumors of the
brain and meninges: results from the Adelaide adult brain tumor study.
Int J Cancer 1992, 51(1):20–27.
19. Blowers L, Preston-Martin S, Mack WJ: Dietary and other lifestyle factors of
women with brain gliomas in Los Angeles county (California, USA).
Cancer Causes Control 1997, 8(1):5–12.
20. Schlehofer B, Hettinger I, Ryan P, Blettner M, Preston-Martin S, Little J, Arslan
A, Ahlbom A, Giles GG, Howe GR, Ménégoz F, Rodvall Y, Choi WN,
Wahrendorf J: Occupational risk factors for low grade and high grade
glioma: results from an international case control study of adult brain
tumours. Int J Cancer 2005, 113(1):116–125.
21. Musicco M, Filippini G, Bordo BM, Melotto A, Morello G, Berrino F: Gliomas
and occupational exposure to carcinogens: case–control study. Am J
Epidemiol 1982, 116(5):782–790.
22. Ahlbom A, Navier IL, Norell S, Olin R, Spannare B: Nonoccupational risk
indicators for astrocytomas in adults. Am J Epidemiol 1986,
124(2):334–337.
23. Hurley SF, McNeil JJ, Donnan GA, Forbes A, Salzberg M, Giles GG: Tobacco
smoking and alcohol consumption as risk factors for glioma: a case–
control study in Melbourne. J Epidemiol Community Health 1996,
50(4):442–446.
24. Lee M, Wrensch M, Miike R: Dietary and tobacco risk factors for adult
onset glioma in the San Francisco Bay Area (California, USA).
Cancer Causes Control 1997, 8(1):13–24.
25. Mills PK, Preston-Martin S, Annegers JF, Beeson WL, Phillips RL, Fraser GE:
Risk factors for tumors of the brain and cranial meninges in Seventh-Day
Adventists. Neuroepidemiology 1989, 8(5):266–275.
26. Holick CN, Giovannucci EL, Rosner B, Stampfer MJ, Michaud DS: Prospective
study of cigarette smoking and adult glioma: dosage, duration, and
latency. Neuro Oncol 2007, 9(3):326–334.
27. Benson VS, Pirie K, Green J, Casabonne D, Beral V: Lifestyle factors and
primary glioma and meningioma tumours in the Million Women Study
cohort. Br J Cancer 2008, 99(1):185–190.
28. Efird JT, Friedman GD, Sidney S, Klatsky A, Habel LA, Udaltsova NV, Van den
Eeden S, Nelson LM: The risk for malignant primary adult-onset glioma in
a large, multiethnic, managed-care cohort: cigarette smoking and other
lifestyle behaviors. J Neurooncol 2004, 68(1):57–69.
29. Silvera SA, Miller AB, Rohan TE: Cigarette smoking and risk of glioma: a
prospective cohort study. Int J Cancer 2006, 118(7):1848–1851.
30. Mandelzweig L, Novikov I, Sadetzki S: Smoking and risk of glioma: a meta-
analysis. Cancer Causes Control 2009, 20(10):1927–1938.
31. Schneider B, Pulhorn H, Rohrig B, Rainov NG: Predisposing conditions and
risk factors for development of symptomatic meningioma in adults.
Cancer Detect Prev 2005, 29(5):440–447.
32. Lee E, Grutsch J, Persky V, Glick R, Mendes J, Davis F: Association of
meningioma with reproductive factors. Int J Cancer 2006,
119(5):1152–1157.
33. Preston-Martin S, Yu MC, Henderson BE, Roberts C: Risk factors for
meningiomas in men in Los Angeles County. J Natl Cancer Inst 1983,
70(5):863–866.
34. Hu J, Little J, Xu T, Zhao X, Guo L, Jia X, Huang G, Bi D, Liu R: Risk factors
for meningioma in adults: a case–control study in northeast China. Int J
Cancer 1999, 83(3):299–304.
35. Phillips LE, Longstreth WT Jr, Koepsell T, Custer BS, Kukull WA, van Belle G:
Active and passive cigarette smoking and risk of intracranial
meningioma. Neuroepidemiology 2005, 24(3):117–122.36. Batty GD, Kivimaki M, Gray L, Davey Smith G, Marmot MG, Shipley MJ:
Cigarette smoking and site-specific cancer mortality: testing uncertain
associations using extended follow-up of the original Whitehall study.
Ann Oncol 2008, 19(5):996–1002.
37. International Agency for Research in Cancer (IARC): Tobacco Smoking. In
IARC Monographs, A Review of Human Carcinogens: Personal Habits and
Indoor Combustions. Lyon: IARC Press; 2012. 100E: 43-211.
38. Cardis E, Richardson L, Deltour I, Armstrong B, Feychting M, Johansen C,
Kilkenny M, McKinney P, Modan B, Sadetzki S, Schüz J, Swerdlow A, Vrijheid
M, Auvinen A, Berg G, Blettner M, Bowman J, Brown J, Chetrit A, Christensen
HC, Cook A, Hepworth S, Giles G, Hours M, Iavarone I, Jarus-Hakak A,
Klaeboe L, Krewski D, Lagorio S, Lönn S, et al: The INTERPHONE study:
design, epidemiological methods, and description of the study
population. Eur J Epidemiol 2007, 22(9):647–664.
39. Weiss NS: Subgroup-specific associations in the face of overall null
results: should we rush in or fear to tread? Cancer Epidemiol Biomarkers
Prev 2008, 17(6):1297–1299.
40. Chen J, Wacholder S, Morton LM, Bhatti P, Hartge P: Quantifying selection
bias in epidemiologic studies. Am J Epidemiol 2005, 161(Suppl):S145.
41. Hartge P: Participation in population studies. Epidemiology 2006,
17(3):252–254.
42. Millar WJ: Reaching smokers with lower educational attainment. In
Statistics Canada Health Reports. Ottawa: Statistics Canada Health Analysis
Division; 1996. 8(2):11-19(Eng); 13-22(Fre).
43. Shields M: Smoking-prevalence, bans and exposure to second-hand
smoke. Health Rep 2007, 18(3):67–85.
doi:10.1186/1476-069X-13-55
Cite this article as: Vida et al.: Brain tumours and cigarette smoking:
analysis of the INTERPHONE Canada case–control study. Environmental
Health 2014 13:55.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
